The Effect of Incentive Spirometry Added to Routine Physiotherapy Program on Hemodynamic Responses and Hospital Stay in Patients With COPD Exacerbation

Not Applicable

Completed

• Conditions: COPD Exacerbation
• Interventions: Other: Conventional Chest Physiotherapy; Other: Conventional Chest Physiotherapy+Incentive Spirometry

• Registration Number: NCT04170361
• Lead Sponsor: Bezmialem Vakif University

Brief Summary

COPD; it is a common, preventable and treatable disease that is associated with increased chronic inflammatory responses in the airways and lungs against harmful gases and particles, and that it manages progressive airflow. The definition of exacerbation is defined as an acute onset with a change in where daily differences in the main symptoms occur and which may occur with the presence of drugs. The number of exacerbations in the course of the disease is between 1-3 years on average. Routine physiotherapy treatment in COPD exacerbation is expected to increase lung volume and effective removal of airway secretions. The concept of physiotherapy programs is vibration, thoracic expression exercise, positive expiratory pressure therapy and gait programs.

An incentive spirometer is a simple, inexpensive device to adjust lung tissue re-expansion by increasing lung volumes and diaphragmatic mobility, providing maximal inspiration with termination control without a resistive loading. In COPD patients, the use of incentive spirometry is to increase alveolar ventilation and oxygenation in lifestyle.

There are a limited number of studies in the literature regarding the results of the use of incentive spirometry in COPD patients. The results of postoperative results of incentive spirometry in COPD patients were tried and established on pulmonary complications, diseases, postoperative dyspnea perception and lifestyle. The importance of the investigator's research; this is the first study to evaluate hemodynamic responses and hospitalization plans of incentive spirometer and routine physiotherapy program in COPD exacerbations.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-11-18
• Study First Submitted QC: 2019-11-19
• Study First Posted: 2019-11-20
• Study Start: 2021-09-21
• Primary Completion: 2022-03-01
• Study Completion: 2022-03-22
• Status Verified: 2022-04
• Last Update Submitted: 2022-04-14
• Last Update Posted: 2022-04-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

• Being diagnosed with COPD exacerbation
• Hemodynamically stable
• To be conscious and voluntarily agree to participate in the study

Exclusion Criteria

• Existence of neurological, cardiovascular and musculoskeletal problems to prevent exercise
• Having chronic respiratory disease other than COPD

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control Group	Conventional Chest Physiotherapy	Patients will be admitted to chest physiotherapy program including breathing exercises, modified postural drainage and percussion, lower-upper extremity mobilization exercises and posture exercises once a day during hospitalization.
Training Group	Conventional Chest Physiotherapy+Incentive Spirometry	In addition to conventional chest physiotherapy program, patients in this group will also be taught to use Triflo ® and apply at two-hour intervals.
Training Group	Conventional Chest Physiotherapy	In addition to conventional chest physiotherapy program, patients in this group will also be taught to use Triflo ® and apply at two-hour intervals.

Primary Outcome Measures

Name	Time	Method
Systolic and diastolic blood pressure	30 minutes	Blood pressure will be measured before and after physiotherapy program with monometer from the arm
Forced Expiratory Volume in 1 second (FEV1)	30 minutes	FEV1 will be measured using MIR brand SPIRODOC model portable spirometer and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)
Oxygen saturation	30 minutes	The oxygen saturation response will be measured before and after physiotherapy program with pulse oximeter.
Respiratory rate	30 minutes	Blood pressure will be measured before and after physiotherapy program with observation
Forced Expiratory Volume 25-75%	30 minutes	FEF 25-75% will be measured using MIR brand SPIRODOC model portable spirometer and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)
Heart rate	30 minutes	The hearth rate response will be measured before and after after physiotherapy program with pulse oximeter.
Forced Vital Capacity (FVC)	30 minutes	FVC will be measured using MIR brand SPIRODOC model portable spirometer and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)
Peak Expiratory Flow (PEF)	30 minutes	PEF will be measured using MIR brand SPIRODOC model portable spirometer and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)

Trial Locations

Locations (2)

Bezmialem Vakif University, Department of Physiotheraphy and Rehabilitation; 🇹🇷 Istanbul, Turkey

Meltem Kaya; 🇹🇷 İstanbul, Turkey